Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria by unknown
BREAST
Evaluation of low-energy contrast-enhanced spectral
mammography images by comparing them to full-field digital
mammography using EUREF image quality criteria
U. C. Lalji & C. R. L. P. N. Jeukens & I. Houben & P. J. Nelemans &
R. E. van Engen & E. van Wylick & R. G. H. Beets-Tan &
J. E. Wildberger & L. E. Paulis & M. B. I. Lobbes
Received: 24 December 2014 /Revised: 2 February 2015 /Accepted: 24 February 2015 /Published online: 27 March 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Objective Contrast-enhanced spectral mammography (CESM)
examination results in a low-energy (LE) and contrast-
enhanced image. The LE appears similar to a full-field digital
mammogram (FFDM). Our aim was to evaluate LE CESM
image quality by comparing it to FFDM using criteria defined
by the European Reference Organization for Quality Assured
Breast Screening and Diagnostic Services (EUREF).
Methods A total of 147 cases with both FFDM and LE images
were independently scored by two experienced radiologists
using these (20) EUREF criteria. Contrast detail measure-
ments were performed using a dedicated phantom. Differ-
ences in image quality scores, average glandular dose, and
contrast detail measurements between LE and FFDM were
tested for statistical significance.
Results No significant differences in image quality scores
were observed between LE and FFDM images for 17 out of
20 criteria. LE scored significantly lower on one criterion
regarding the sharpness of the pectoral muscle (p<0.001),
and significantly better on two criteria on the visualization of
micro-calcifications (p=0.02 and p=0.034). Dose and con-
trast detail measurements did not reveal any physical expla-
nation for these observed differences.
Conclusions Low-energy CESM images are non-inferior to
FFDM images. From this perspective FFDM can be omitted
in patients with an indication for CESM.
Key Points
• Low-energy CESM images are non-inferior to FFDM
images.
• Micro-calcifications are significantly more visible on LE
CESM than on FFDM.
• There is no physical explanation for this improved visibility
of micro-calcifications.
• There is no need for an extra FFDM when CESM is
indicated.
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Introduction
In breast imaging, mammography continues to play an impor-
tant role. The diagnostic performance of mammography is
good, but depends heavily on breast density [1]. With the
introduction of digital mammography, several applications
that increase diagnostic accuracy (even in dense breasts) have
been developed. One of these is contrast-enhanced spectral
mammography (CESM). Recent studies continue to show that
CESM is superior to conventional mammography in breast
cancer detection [2–5].
A standard CESM examination consists of three sets of
images per exposure: a low energy (LE) image, a high energy
image, and a recombined image (Fig. 1). The LE image is
acquired at peak kilovoltage (kVp) values ranging from 26–
31 kVp. In this way, the entire x-ray spectrum is below the k-
edge of iodine (which is 33.2 keV) [3]. As a result, the LE
image resembles a full-field digital mammogram (FFDM),
although iodine contrast is already present within the breast.
However, in order to omit FFDM in cases for which CESM is
indicated (for example in postmenopausal womenwith a high-
ly suspicious palpable breast mass), LE images have to com-
ply with the high image quality standards used in breast im-
aging and should at least be non-inferior to their FFDM coun-
terpart. The high energy image is not used for diagnostic pur-
poses, but is used in post-processing to create the recombined
image, in which areas of enhancement can be appreciated.
In this retrospective study, we aimed to study the differ-
ences between LE and FFDM images in a standardized and
structured manner. Our primary study aim was to evaluate the
image quality of LE images using FFDM acquired at the
Dutch Breast Cancer Screening Program (DBCSP) as a refer-
ence standard and using the image quality criteria defined by
the European Reference Organization for Quality Assured
Breast Screening and Diagnostic Services (EUREF) [6]. Our
secondary aim was to evaluate the differences in dose and
contrast detail measurements between the two images.
Materials and methods
In The Netherlands, women aged 50–75 years are invited to
participate in the DBCSP every 2 years [7]. If a breast abnor-
mality is detected, women are referred to a hospital of their
choice for further analysis. In our institute, every recalled pa-
tient is eligible to undergo CESM, unless contraindications for
the use of iodine-based contrast agents exist, such as an in-
creased risk of developing contrast-induced nephropathy or
known contrast allergies.
In this study, data fromwomen that underwent CESM for a
screen-detected breast abnormality were collected between
July 2013 and February 2014. Since they were recalled from
screening, all women had a recent (screening) FFDM exami-
nation for comparison. The need for informed consent was
waived by the local ethics committee.
Image acquisition and analysis
FFDMwas performed on a standard mammography unit used
in the DBSCP (Hologic Selenia, Bedford, MA, USA), where-
as LE images were acquired as part of a CESM (Senographe*
Essential with Senobright* upgrade, GE Healthcare, Chalfont
St Giles, United Kingdom). All images were displayed on a
d e d i c a t e d m ammo g r a p h y w o r k s t a t i o n ( I D I
MammoWorkstation 4.7.0, GE Healthcare, Chalfont St Giles,
UK) equipped with mammography-approved monitors
(Barco Coronis 5MP Mammo, Barco, Kortrijk, Belgium).
Two experienced radiologists (U.L. and M.L., both viewing
Fig. 1 A typical contrast-enhanced spectral mammography (CESM)
examination (only right mediolateral oblique view shown), consisting
of a low-energy (a), high-energy (b) and recombined (c) image. A
suspicious lesion is seen on the low-energy image, showing
enhancement on the recombined image (white arrows). Histopathology
showed invasive ductal carcinoma. The high-energy image is not for
diagnostic purposes but is used for construction of the recombined image
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over 6,000 clinical and screening mammographies annually)
independently scored the images using 20 image quality
criteria defined by EUREF (Table 1). These are criteria
concerning overall diagnostic value, visibility of (micro-) cal-
cifications, tissue visibility at the chest wall and at the skin
line, overall density, as well as sharpness/noise impression [6].
The radiologists were not allowed to change window width or
level settings while scoring the images.
The original EUREF criteria are dichotomous and can only
be answered with ‘yes’ or ‘no’. In order to perform a more
detailed analysis, we decided to use a five-point scoring scale,
with ‘1’ being the least favourable score and ‘5’ the best pos-
sible score for each item. For example, for the question “Are
the vascular structures visible through the dense parenchy-
ma?” a score of ‘1’ would mean that vascular structures were
hardly visible while a score of ‘5’would indicate that visibility
was excellent.
For scoring, the images were divided in two datasets, each
containing either the FFDM or LE image of a patient. Patients
were randomized with respect to the order in which images
were evaluated: LE first and FFDM second, or vice versa.
Randomization was performed to prevent recall bias. The
LE and FFDM images were viewed separately by both radi-
ologists with a 6-week interval between the scoring of the first
and second image set. Both radiologists were blinded for each
other’s scores. In case of discrepancies consensus was reached
by both radiologists favouring the lowest score given for that
criterion.
Dose measurements
The Entrance Surface Air Kerma (ESAK) and Average Glan-
dular Dose (AGD) were determined according to the method
described in European guidelines [6]. In short, tube output of
both mammography units was determined by measuring the
air kerma using a dosimeter with a dedicated mammography
probe calibrated for the target/filter combinations used in our
measurements (Unfors RaySafe; Billdall, Sweden). The probe
was placed on the bucky table below the compression paddle
touching it.
Tube output was determined with current-time product
50 mAs (CESM)/70 mAs (FFDM) for all target/filter combi-
nations observed in respectively the LE and FFDM patient
groups. For each target/filter combination tube output
Table 1 Image quality criteria scores. The results of themaximum (5) score for FFDMand CESM in percentages and themedian scores for FFDM and
CESM are presented
Image quality criteria (N=147) FFDM 5
score








Is there a good visualization of the skin line? 93.2 % 97.3 % 0.109 5 5 0.058
Are the vascular structures visible through the dense parenchyma? 98.6 % 100.0 % 0.475 5 5 0.18
Is there a sharp visualization of the pectoral muscle? 40.8 % 21.1 % <0.0001** 4 4 <0.0001**
Is there a good visualization of the Cooper’s ligaments and vascular
structures in the subcutaneous and prepectoral area?
99.3 % 100.0 % 1 5 5 0.317
Are the micro-calcifications visualized and well outlined?* 95.0 % 100.0 % 0.042** 5 5 0.02**
Is there sufficient contrast in the dark areas? 99.3 % 98.6 % 1 5 5 0.564
Is there sufficient contrast in the white areas? 99.3 % 97.3 % 0.25 5 5 0.317
Is the glandular tissue sufficiently white? 100.0 % 99.3 % 1 5 5 0.317
Is the background sufficiently dark? 100.0 % 100.0 % 1 5 5 1
Do all images appear in the same way? 99.3 % 100.0 % 1 5 5 0.317
Is there disturbing noise in the dark areas? 100.0 % 100.0 % 1 5 5 1
Is there disturbing noise in the white areas? 99.3 % 99.3 % 1 5 5 0.317
Are there any artefacts? 99.3 % 100.0 % 1 5 5 0.317
Contrast in the white regions? 99.3 % 98.0 % 0.5 5 5 0.564
Contrast in the dark regions? 100.0 % 100.0 % 1 5 5 1
Overall contrast of the images? 99.3 % 98.6 % 1 5 5 0.317
Sharpness of the images? 100.0 % 100.0 % 1 5 5 1
How satisfied are you with the representation of micro-calcifications?* 95.3 % 100.0 % 0.074 5 5 0.034**
How satisfied are you with the representation of opacities? 100.0 % 99.3 % 1 5 5 0.317
How satisfied are you with the representation of the image? 97.3 % 96.6 % 1 5 5 0.655
* for n=120 cases
** statistically significant
FFDM full-field digital mammography, CESM contrast-enhanced spectral mammography
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measurements of three tube voltages covering the whole clin-
ically used range were measured. For the same spectra the
half-value layer (HVL) was alsomeasured using the dosimeter
in the setup described in the European guidelines [6]. The
technical parameters required for the ESAK and AGD calcu-
lation, i.e. kV, target, filter, current-time product and com-
pressed breast thickness (CBT), were obtained for each expo-
sure from the DICOM header of the images. The ESAK was
calculated using the appropriate time-current product and tube
output, which was corrected for breast thickness using the
inverse square law. Next, the AGD was calculated from the
ESAK using the Dance model [6, 8, 9].
Contrast detail phantom measurements
Contrast detail measurements were performed using a CDMA
M phantom (version 3.4, Artinis Medical Systems, Elst,
The Netherlands), which consists of a matrix of gold disks
of diameter range 0.06–2.0 mm and thickness range 0.03–
2.0 μm. The phantom was positioned in the middle of a stack
of polymethylmethacrylate (PMMA) plates of varying thick-
nesses to simulate the clinical range of CBTas described in the
EUREF guidelines [6], where the CDMAM phantom corre-
sponds to 10 mm PMMA thickness. To determine the expo-
sure parameters for each thickness, i.e. target/filter combina-
tion, tube voltage and current-time product, a FFDM or LE
exposure was made in fully automatic exposure control mode.
Using these exposure parameters, 16 exposures were made for
each simulated breast thickness. The unprocessed images
were exported to the analysis software (CDMAM analyzer,
version 2.0.5, Elst, The Netherlands), which analyses the
threshold detectability of the gold disks in each image,
resulting in an average threshold thickness for each disc diam-
eter. Subsequently, we plotted the threshold detection thick-
ness versus the disc diameter on a log-log scale and generated
a contrast-detail curve by performing a fit.
Statistical analyses
For each of the 20 EUREF criteria, the frequency of the
(optimal) ‘5’ score was calculated. Any statistically signifi-
cance between the scores of LE and FFDM images were
assessed using a McNemar test for paired proportions. In ad-
dition, median scores of LE and FFDM images were calculat-
ed, using a Wilcoxon signed rank test to test for statistically
significant differences. In case of micro-calcifications, if none
were observed, ratings (criteria 5 and 18) were scored as ‘not
applicable’.
For the dose measurements, AGD values of the entire pa-
tient population were tested pairwise for differences between
FFDM and LE exposures using a Wilcoxon matched-pair
signed rank test. Furthermore, we studied whether differences
in AGD depended on breast thickness. To this extent, mean
CBTwas calculated for each patient by averaging the CBT of
all exposures taken on both systems, which were four FFDM
and four LE exposures (CC and MLO orientation of left and
right breast). Patients were categorized according to their
mean CBTand the AGDwas statistically tested for differences
between the FFDM and LE groups using a paired sample t-
test.
To compare the detection curves between FFDM and LE in
the contrast detail measurements a multivariable linear regres-
sion analysis was performed to evaluate detection threshold
thickness differences for LE and FFDM. The mammography
method (FFDM or LE) and 1/diameter of the gold discs were
used as covariates, the latter as a first -order approximation of
the theoretical relation stated in the European guidelines [4].
All p-values <0.05 were considered to be statistically sig-
nificant. All statistical analyses were performed using SPSS
(IBM SPSS Statistics for Windows, Version 22.0. Armonk,
NY, USA).
Results
A total of 147 women who underwent CESM for a screen-
detected breast abnormality were included. A total of 588
FFDM images were compared to 588 LE images. Mean age
was 59.5 years (range 49–75 years). Thirty-six of 147 women
were diagnosed with breast cancer (24.5 %). Of these women,
seven were diagnosed with DCIS (4.8 %) and the remaining
29 with invasive carcinoma (19.7 %). The remaining women
were diagnosed with a benign condition as reason for their
referral (such as superposition of glandular tissue as cause
for the abnormality, cysts, fibro-adenoma, papilloma, etc.).
The mean time between FFDM at time of referral and CESM
was 14 days (SD 11 days).
The results of the scores are summarized in Table 1. For
FFDM images, the frequency of the maximum (‘5’) score per
criterion ranged from 40.8 % to 100 %. For LE, this ranged
from 20.1 % to 100 %. For 19 criteria the median score for
both FFDM and LE was 5 with an exception of the visibility
of the pectoral muscle, where the median score of both FFDM
and CESM was 4. In 17 of the 20 image quality criteria, no
significant differences between FFDM and LEwere observed.
One criterion concerning the visibility of the pectoral muscle
showed a maximal score frequency of 40.8 % for FFDM and
20.1% for LE (p<0.0001). Of the two remaining criteria (both
regarding visualization of micro-calcifications) LE score was
better than FFDM score (p=0.02 and p=0.034, respectively;
Table 1).
Figure 2 presents the AGD values of FFDM and LE expo-
sures as a function of compressed breast thickness of all pa-
tients. The average pairwise difference of the AGD values was
42 %, where the AGD of the LE was higher than that of
FFDM (Table 2). Pairwise analysis showed that not only for
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the whole patient population but also for all breast thickness
categories, the LE AGD values were significantly higher than
the FFDM AGD values (Table 2 and 3). Both LE CESM and
FFDM AGD-values were in compliance with the acceptable
limits of the EUREF guidelines [6].
The settings used in the CDMAM phantom measurements
(Table 2) and the resulting AGD values (compare Table 2 to
Fig. 2) are representative for settings used in the patient
groups. Furthermore, the AGD values used in all measure-
ments are well below the achievable dose levels reported in
the EUREF guidelines [6], except for one that is well below
the acceptable limit. Figure 3 shows the threshold thickness of
the observed gold disks versus the gold disk diameter, for each
phantom thickness. The threshold contrast visibility for both
systems is well below the achievable limit values for a stan-
dard breast thickness of 60 mm (50 mm PMMA equivalent)
stated in the EUREF guidelines [6]. For all breast thicknesses
no significant differences in detection threshold thickness
were found between the FFDM and LE curves (p-values of
0.29, 0.10, 0.13, 0.42 and 0.12 for breast thickness of 30, 45,
60, 75 and 90 mm, respectively).
Discussion
CESM is a promising new breast imaging modality that has
been shown to be superior to conventional mammography in
the detection of breast cancer [2, 3, 10]. No studies so far have
compared the quality of the LE images to that of FFDM in a
standardized and structured manner, using well established
EUREF image quality criteria. We demonstrated that for the
majority of image quality criteria there were neither clinically
relevant nor statistically significant differences between these
two modalities. Interestingly, we observed that the visualiza-
tion of micro-calcifications is superior in LE images. Based on
additional dose and contrast detail measurements, we could
not find any physical explanation for these observations.
In 17 of 20 EUREF criteria no statistically significant dif-
ferences were observed, indicating that there is hardly any
difference between FFDM and LE in terms of image quality.
The delineation of the pectoral muscle was scored significant-
ly lower for LE when compared to FFDM. However, in our
experience this will not cause any relevant diagnostic di-
lemmas, as the recombined image can also be used for assess-
ment of lesions covering the pectoral muscle. In a worst-case
scenario, an additional FFDM in mediolateral oblique view
can still be considered if the lesion of interest is adjacent to
the pectoral muscle. Figure 4 shows an example of the ob-
scured pectoral muscle on LE versus FFDM. More interest-
ingly, we observed a statistically significant improvement of
micro-calcification visualization in LE images when com-
pared to FFDM. This latter finding can indeed be of interest,
as it suggests that ductal carcinoma in situ can be diagnosed
more confidently or its extent might be assessed more accu-
rately using LE CESM images. However, the limited number
of DCIS cases (n=7) in this study restrained us from further
testing this hypothesis.
Fig. 2 Average glandular dose (AGD) of the complete patient group
values plotted against compressed breast thickness for the full-field
digital mammography (FFDM) (open red circles) and low-energy (LE)
(solid black triangles) exposures



























32 30 10/Ph/10 W Rh 26 61 0.79 Mo Rh 27 45 1.1
45 40 10/Ph/10/10 W Rh 28 86 1.1 Rh Rh 29 71 1.8
60 50 10/10/Ph/10/10 W Rh 32 81 1.3 Rh Rh 31 80 2.3
75 60 25/Ph/25 W Ag 30 111 1.7 Rh Rh 30 140 3.6
90 70 25/Ph/25/10 W Ag 34 96 1.8 Rh Rh 30 140 3.8
*Ph=CDMAM phantom, 10 and 25 refer to the thickness of the PMMA plates (mm)
FFDM full-field digital mammography, LE low energy, CESM contrast-enhanced spectral mammography, AGD average glandular dose
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To further explain the differences in image quality scores
we performed additional dose and contrast detail measure-
ments. The average AGD of the FFDM exposure is 1.7±
0.4 mGy, while the AGD of the LE exposure is 2.3±
0.7 mGy. The difference reflects differences in AOP settings
for FFDM and LE CESM, i.e. target/filter combination, tube
voltage and tube load, where for LE CESM the prerequisite
was that the LE acquisition should be suitable for reconstruc-
tion of the contrast-enhanced image. Furthermore, the doses
used in these examinations were in agreement with results
Table 3 AGD per exposure for FFDM and LE images for five compressed breast thickness categories and for all patients, p-values denote the














<40 mm 13 1.15 0.24 0.69–1.75 1.6 0.3 1.0 – 2.0 <0.001
41–50 mm 31 1.3 0.3 0.9–2.6 1.8 0.1 1.5 – 2.5 <0.001
51–70 mm 87 1.8 0.3 1.1–2.8 2.5 0.6 1.6 – 3.6 <0.001
71–80 mm 13 2.0 0.3 1.4–2.7 3.22 0.12 3.03 – 3.52 <0.001
>81 mm 3 2.19 0.23 1.90–2.71 2.95 0.18 2.67 – 3.26 <0.001
All 147 1.7 0.4 0.7–2.8 2.3 0.7 1.0 – 3.6 <0.001
FFDM full-field digital mammography, CESM contrast-enhanced spectral mammography, AGD average glandular dose, LE low energy
Fig. 3 Threshold gold thickness detected as a function of gold disk
diameter for a range of phantom thicknesses corresponding to breast
thicknesses from (A) 32 mm to (E) 90 mm. The solid and dashed lines
are data fits. In (C) the acceptable and achievable limits of the EUREF
guidelines are also shown
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from a previous study [11] showing that the observed image
quality differences could not be explained by using abnormal
radiation doses in one of the techniques. We also performed
CDMAM contrast detail measurements to investigate whether
the observed differences in scoring could be explained. The
different scores concerning pectoral muscle visibility could
not be assessed by these measurements as this structure is
not represented in the phantom. The detectability of smaller
diameter gold disks in this phantom was found to relate to
micro-calcification detection [12]. We did not observe a sig-
nificant difference in the contrast detail curves, indicating that
FFDM and LE CESM have similar contrast detail detection.
FFDM and LE CESM both comply with the acceptable as
well as the achievable limits for contrast threshold visibility.
Since the CDMAM analysis was performed on the unpro-
cessed images, it can be concluded that the observed differ-
ences were not due to hardware differences. A possible expla-
nation for the improved calcification detection may be found
in different post-processing techniques performed to obtain
the final image from the unprocessed images. Unfortunately,
we are not able to further evaluate the effect of these post-
processing steps in our phantom or clinical measurements.
Only two previous papers focused on the potential of LE
images as replacement for FFDM. Fallenberg et al. [13] fo-
cused on the ability of cancer detection and size estimation of
bilateral CESM, digital mammography, and the combination
of CESM and mammography in 107 patients. They did not
use image quality criteria such as those suggested by EUREF.
In their study, sensitivity of mammography was 77.9 %,
which increased to approximately 95 % when using CESM
alone or the combination of CESM and mammography, while
CESM alone showed the best correlation with pathology
regarding tumour size measurements. Although there are min-
imal and hardly noticeable differences in attenuation due to
the iodine contrast agent already present in the breast during
the LE acquisition, the improved sensitivity was suggested to
be attributed to a slight enhancement of cancers even on the
LE images. In addition, our observation suggests that micro-
calcifications can be better visualized on LE images. Most
importantly, neither Fallenberg et al.’s study nor our study
showed any signs of inferiority of LE images compared to
mammography.
Francescone et al. [14] studied 170 examinations in 88
women and compared the LE images with FFDM images that
were obtained within 6 months. They mainly focused on tech-
nical parameters including posterior nipple line distance, com-
pression thickness and compression force on the MLO projec-
tion. Similar to Fallenberg et al., they compared tumour size
measurements on both modalities. An important limitation to
this study was that the readers were not blinded and analysis
was performed in a side-by-side comparison, thereby poten-
tially introducing bias. No statistically significant differences
were observed for all studies’ parameters between LE and
FFDM, but this study also did not use standardized image
quality criteria such as suggested by EUREF.
Although the studies of Fallenberg et al. and Francescone
et al. suggested non-inferiority of LE CESM compared to
FFDM, our study contains important additional information
as it assessed differences by using well-defined image quality
criteria in a structured and standardized manner in the largest
study population so far. Nevertheless, when all current evi-
dence is summarized, it is valid and safe to conclude that LE
CESM images are indeed non-inferior to FFDM, and might
even be superior in terms of breast cancer detection and micro-
Fig. 4 A 54-year-old female recalled from the breast cancer screening
program (full-field digital mammography (FFDM) image) for a round
mass in the left breast (*), also visible on the low-energy contrast-
enhanced spectral mammography (CESM) image. On the recombined
image, an ‘eclipse sign’ is visible, suggesting a cyst, and confirmed by
targeted ultrasound. In this case, the sharpness of the pectoral muscle was
scored ‘5’ on the FFDM image. On the low-energy CESM image, the
delineation of the pectoral muscle was lost (white arrows), resulting in a
score of ‘3’ from both radiologists
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calcification evaluation. This means that FFDM can be omit-
ted if a direct indication for CESM exists, for example in
(postmenopausal) women with a suspicious palpable breast
mass, or women with incidental suspicious breast findings
observed in other imaging exams, such as chest CT
examinations.
Our study has some limitations. First, FFDM images were
made with a different mammography unit than the LE images.
Both radiologists, however, were experienced in reading im-
ages from both mammography units. Consequently, they could
distinguish the FFDM from the LE images based on their ap-
pearance alone. However, our current (random) reading strate-
gy, including a 6-week interval, minimized the effect of any
recall bias. Another limitation is that in our contrast detail phan-
tom studies, we used the unprocessed images for data analysis.
This is the standardized method, recommended by EUREF, as
the post-processing may introduce image artefacts and may
slightly differ from the mammography post-processing as an
object-dependent histogram of texture analysis may be used.
Therefore, it was not possible to determine whether post-
processing improved the contrast-detail detection, and, thus,
whether this would be an explanation for the significantly im-
proved detection of micro-calcifications by LE images.
Conclusion
The LE images obtained as part of a CESM examination are
similar to FFDM for the vast majority of EUREF image qual-
ity criteria. The slightly poorer delineation of the pectoral
muscle on LE images does not seem to cause diagnostic di-
lemmas. More importantly, micro-calcifications are better vi-
sualized on LE images when compared to FFDM. In conclu-
sion, using LE images for diagnostic purposes is safe.
Acknowledgments The scientific guarantor of this publication is Dr.
M.B.I. Lobbes, M.D., PhD. The authors of this manuscript declare no
relationships with any companies whose products or services may be
related to the subject matter of the article. The authors state that this work
has not received any funding. P.J. Nelemans, PhD. kindly provided sta-
tistical advice for this manuscript. Institutional Review Board approval
was obtained.
Written informed consent was waived by the Institutional Review
Board. Methodology: retrospective, observational, performed at one
institution.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any non-
commercial use, distribution, and reproduction in any medium, provided
the original author(s) and the source are credited.
References
1. Carney PA, Miglioretti DL, Yankaskas BC et al (2003) Individual
and combined effects of age, breast density, and hormone replace-
ment therapy use on the accuracy of screening mammography. Ann
Intern Med 138:168–175
2. Lalji U, Lobbes M (2014) Contrast-enhanced dual-energy mammog-
raphy: a promising new imaging tool in breast cancer detection.
Womens Health (Lond Engl) 10:289–298
3. Lobbes MBI, Smidt ML, Houwers J et al (2013) Contrast enhanced
mammography: techniques, current results, and potential indications.
Clin Radiol 68:935–944
4. Blum KS, Rubbert C, Mathys B et al (2014) Use of contrast-
enhanced spectral mammography for intramammary cancer staging:
preliminary results. Acad Radiol 21:1363–1369
5. Luczyńska E, Heinze-Paluchowska S, Dyczek S et al (2014)
Contrast-enhanced spectral mammography: comparison with con-
ventional mammography and histopathology in 152 women.
Korean J Radiol 15:689–696
6. EUREF European Guidelines - EUREF | European Reference
Organisation for Quality Assured Breast Screening and
Diagnostic Services (2013) European guidelines for Guality
Assurance in breast cancer screening and diagnosis, Fourth
edition Supplements. availible at: http://www.euref.org/
european-guidelines
7. Timmers JMH, Verbeek ALM, IntHout J, et al. (2013) Breast
cancer risk prediction model: a nomogram based on common
mammographic screening findings. Eur Radiol 23:2413–9. doi:
10.1007/s00330-013-2836-88
8. Dance DR, Skinner CL, Young KC et al (2000) Additional
factors for the estimation of mean glandular breast dose using
the UK mammography dosimetry protocol. Phys Med Biol 45:
3225–3240
9. Dance DR, Young KC, van Engen RE (2009) Further factors for the
estimation of mean glandular dose using the United Kingdom,
European and IAEA breast dosimetry protocols. Phys Med Biol 54:
4361–4372
10. Lobbes MBI, Lalji U, Houwers J et al (2014) Contrast-enhanced
spectral mammography in patients referred from the breast cancer
screening programme. Eur Radiol 24:1668–1676
11. Jeukens CRLPN, Lalji UC, Meijer E et al (2014) Radiation exposure
of contrast-enhanced spectral mammography compared with full-
field digital mammography. Invest Radiol. doi:10.1097/RLI.
0000000000000068
12. Warren LM, Green FH, Shrestha L et al (2013) Validation of simu-
lation of calcifications for observer studies in digital mammography.
Phys Med Biol 58:N217–N228
13. Fallenberg EM, Dromain C, Diekmann F et al (2014) Contrast-
enhanced spectral mammography: does mammography provide ad-
ditional clinical benefits or can some radiation exposure be avoided?
Breast Cancer Res Treat 146:371–381
14. Francescone MA, Jochelson MS, Dershaw DD et al (2014)
Low energy mammogram obtained in contrast-enhanced dig-
ital mammography (CEDM) is comparable to routine full-
field digital mammography (FFDM). Eur J Radiol 83:1350–
1355
2820 Eur Radiol (2015) 25:2813–2820
